Breakthrough in Lung Cancer Treatment: Positive Phase 3 OPTITROP-Lung04 Trial Results for Sacituzumab Tirumotecan Unveiled
Enhertu's Triumph: AstraZeneca and Daiichi Sankyo Unveil Pivotal Phase 3 Data, Reshaping Cancer Care
A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025
Breakthrough in Breast Cancer Treatment: Kelun Biotech's Sacituzumab Tirumotecan Shines at ESMO 2025
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
Glenmark Forges Major Oncology Alliance with Hengrui for Advanced Cancer Therapy
Corbus Pharmaceuticals' Lead Drug Receives Esteemed FDA Fast Track Designation
BioNTech Soars: Landmark Phase 3 Success for Breast Cancer Therapy